Rokro Pharma Private Limited
About Rokro Pharma Private Limited
Data last updated:
Rokro Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2019PTC130679. Its GSTIN is 36AAJCR4343K1Z2 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Kusuma Kambala Mani Kumari and Kambala Rahul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 287/13/A P.No. 2rd No.14 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.56 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹7.64 Lakh (net margin -33.9%) and EBITDA of -₹6.68 Lakh (EBITDA margin -29.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rokro Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8 – 2 – 287/13/A P.No. 2rd No.14 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rokro Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rokro Pharma Private Limited
FY 2025 filings availableRokro Pharma Private Limited reported revenue of ₹22.56 Lakh (up 7247% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -29.6% | ||||
| Net Profit Margin | -33.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rokro Pharma Private Limited, buy the company report.
Board of directors of Rokro Pharma Private Limited
Rokro Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kusuma Kambala Mani Kumari Also directs: Elevate Management Solutions LLP, Rahul Riches Private Limited, Sri Ramprasad Skyscrapers Private Limited and 2 more | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
| Kambala Rahul | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Rokro Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Muse Healthcare Private Limited | ₹22.76 Lakh (FY 2025) | -19.0% | Lucknow, Uttar Pradesh, India | |||
| Emphaatic Pharmaceuticals Private Limited | ₹22.69 Lakh (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Rokro Pharma Private Limitedthis company | ₹22.56 Lakh (FY 2025) | -₹7.64 Lakh | -33.9% | 7247.0% | Hyderabad, Telangana, India | |
| Pearl Lifecare Private Limited | ₹22.56 Lakh (FY 2023) | -29.0% | Ahmedabad, Gujarat, India | |||
| Miracle Medilink Private Limited | ₹22.56 Lakh (FY 2020) | 45.0% | Patna, Bihar, India | |||
| Rivaan Solution Private Limited | ₹22.5 Lakh (FY 2025) | New Delhi, Delhi, India |
To see the full peer comparison of Rokro Pharma Private Limited, buy the company report.
Auditor
Rokro Pharma Private Limited is audited by VISWESWARA RAO & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISWESWARA RAO & ASSOCIATES | FY 2021 | 005774S |
Shareholding
The shareholding of Rokro Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rokro Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rokro Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rokro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rokro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCR4343K1Z2 | Telangana | Active | 30 Aug 2019 |
To see the full GST registrations and return filing status of Rokro Pharma Private Limited, buy the company report.
Recent activity
Rokro Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Jammalamadaka Venkata Subrahmanyam ceased to be Director on 13 Feb 2020.
Frequently asked questions
Rokro Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U74999TG2019PTC130679.
Rokro Pharma has 2 current directors:
- Kusuma Kambala Mani Kumari - Director
- Kambala Rahul - Director
The latest financial statements of Rokro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rokro Pharma is 36AAJCR4343K1Z2, registered in Telangana.
The CIN (Corporate Identification Number) of Rokro Pharma is U74999TG2019PTC130679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rokro Pharma was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rokro Pharma by revenue are Muse Healthcare Private Limited, Emphaatic Pharmaceuticals Private Limited, Pearl Lifecare Private Limited, Miracle Medilink Private Limited, Rivaan Solution Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Jammalamadaka Venkata Subrahmanyam ceased to be Director on 13 Feb 2020. Kusuma Kambala Mani Kumari was appointed as Director on 13 Feb 2020. Kambala Rahul was appointed as Director on 19 Feb 2019.
The registered office of Rokro Pharma is at 8 – 2 – 28713A P.No. 2rd No.14 Banjara Hills, Hyderabad, Telangana, India – 500034.
Rokro Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Rokro Pharma is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
